Facial analysis technology for the detection of Down syndrome in the Democratic Republic of the Congo

Down syndrome is one of the most common chromosomal anomalies affecting the world's population, with an estimated frequency of 1 in 700 live births. Despite its relatively high prevalence, diagnostic rates based on clinical features have remained under 70% for most of the developed world and ev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of medical genetics 2021-09, Vol.64 (9), p.104267-104267, Article 104267
Hauptverfasser: Porras, Antonio R., Bramble, Matthew S., Mosema Be Amoti, Kizito, Spencer, D'Andre, Dakande, Cécile, Manya, Hans, Vashist, Neerja, Likuba, Esther, Ebwel, Joachim Mukau, Musasa, Céleste, Malherbe, Helen, Mohammed, Bilal, Tor-Diez, Carlos, Ngoyi, Dieudonné Mumba, Katumbay, Désiré Tshala, Linguraru, Marius George, Vilain, Eric
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Down syndrome is one of the most common chromosomal anomalies affecting the world's population, with an estimated frequency of 1 in 700 live births. Despite its relatively high prevalence, diagnostic rates based on clinical features have remained under 70% for most of the developed world and even lower in countries with limited resources. While genetic and cytogenetic confirmation greatly increases the diagnostic rate, such resources are often non-existent in many low- and middle-income countries, particularly in Sub-Saharan Africa. To address the needs of countries with limited resources, the implementation of mobile, user-friendly and affordable technologies that aid in diagnosis would greatly increase the odds of success for a child born with a genetic condition. Given that the Democratic Republic of the Congo is estimated to have one of the highest rates of birth defects in the world, our team sought to determine if smartphone-based facial analysis technology could accurately detect Down syndrome in individuals of Congolese descent. Prior to technology training, we confirmed the presence of trisomy 21 using low-cost genomic applications that do not need advanced expertise to utilize and are available in many low-resourced countries. Our software technology trained on 132 Congolese subjects had a significantly improved performance (91.67% accuracy, 95.45% sensitivity, 87.88% specificity) when compared to previous technology trained on individuals who are not of Congolese origin (p 
ISSN:1769-7212
1878-0849
DOI:10.1016/j.ejmg.2021.104267